Manuscripts
Showing 1533 manuscripts.
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe
Citation
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe. AIDS. 2012. 26: 325-33. PMID: 22112598Year
2012
Journal
AIDS
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.
Citation
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.. Archives of Pediatrics and Adolescent Medicine. 2012. 166: 528-35. PMID: 22312169Year
2012
Journal
Archives of Pediatrics and Adolescent Medicine
Study
P1055
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings
Citation
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings. Pediatrics. 2012. 129: e1525-e1532. PMID: 22585772Year
2012
Journal
Pediatrics
Study
P1054
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection
Citation
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection. New England Journal of Medicine. 2012. 366: 2368-79. PMID: 22716975Year
2012
Journal
New England Journal of Medicine
Study
P1043/HPTN 040
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children
Citation
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children. Pediaric Infectious Disease Journal. 2012. 31: 47-52. PMID: 21987006Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1065
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing
Citation
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing. Clinical Pharmacology & Therapeutics. 2012. 91: 243-249. PMID: 22190064Year
2012
Journal
Clinical Pharmacology & Therapeutics
Study
P1030
Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025
Citation
Kunjal Patel, Marcia Mitchell, Gwendolyn B Scott, Jennifer S Read, Yanling Huo. Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. Journal of Pediatric Infectious Disease Society. 2012. 1: 92-102. PMID: 23687574Year
2012
Journal
Journal of Pediatric Infectious Disease Society
Study
P1025
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus
Citation
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus. Pediatrics. 2012. 161: 676-81. PMID: 22622049Year
2012
Journal
Pediatrics
Study
P1065
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
Citation
Edmund Capparelli, Chureeratana Bowonwatanuwong, Sinart Prommas, Pannee Sirivatanapa, Prapap Yuthavisuthi, Chanon Neungton, Yanling Huo, Elizabeth Smith, Brookie M Best, Mark Mirochnick, IMPAACT P1026s Team, Tim R Cressey, Alice Stek. Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. Journal of Acquired Immune Deficiency Syndromes. 2012. 59: 245-252. PMID: 22083071Year
2012
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age
Citation
Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age. AIDS. 2012. 26: 1483-90. PMID: 22555165Year
2012
Journal
AIDS
Study
P1030